BioPartner UK appoints Kam Dhaliwal as new Advisory Board Member

Kam is a passionate advocate of new, impactful technology and an experienced business developer in the field of drug discovery and preclinical research. He is SVP Alliance Management at bit.bio, an award-winning human synthetic biology company based in Cambridge, UK.

BioPartner works closely with UK bioscience sector stakeholders including regional networks, national trade associations, and government departments; to promote UK expertise and to provide cost-effective access to overseas events, opportunities, and new markets for UK-based organisations. Kam joins Rachel Hemsley, Paul Clewlow, Alasdair Stamps, Will Watson, Dave Mead, and Hakan Goker.

Lin Bateson, Chief Executive of BioPartner, said, “We have established a significant UK presence at
several international conferences over the past 12 years, and we have created many networking and
business opportunities for UK companies. Having such experienced Business Development
professionals as Advisors helps to ensure our services to industry are appropriate and the best they can be, particularly as the events industry returns to normal following the challenges of the global covid
pandemic.”